Navigation Links
Catching Alzheimer’s Disease Earl

A new test may be an important tool in the fight against Alzheimer’s disease. A study reported in Clinical Electroencephalography highlights the use of an electrical brain test to detect the disease earlier, which may lead to improved treatment. The test, known as an electrophysiological test, detects impaired memory, which is known to precede the disease.//
Researchers found 65 percent of patients with impaired memory would have been missed by using traditional methods of memory testing. They say the new method, called P300 latency testing, was more sensitive at detecting changes in cerebral function.

The authors of the study from New York and the University of North Texas are confident this new testing method may be able to partially reverse Alzheimer’s. It is well documented that if Alzheimer’s is caught early, some medications can slow the process. This study is particularly important because the number of people aged 60 years and older will increase from one in 10 currently to one in six by the year 2050. After age 60, the incidence of dementia doubles every five years. Therefore, detecting and treating memory loss early could delay or avoid the onset of Alzheimer’s. The researchers say dementia is the fourth-leading cause of death.

According to the study, the P300 latency test should be used as a screening tool. The authors say it is a 15-minute test that can easily be added to a medical visi.
'"/>




Page: 1

Related medicine news :

1. Web Romance Is Catching Up Among The Youths In China
2. Miracle cure for Alzheimer’s around the corner
3. Vaccine for Alzheimer’s diseas
4. High Cholesterol linked to Alzheimer’s diseas
5. Further support for use of statins in Alzheimer’s disease
6. Alzheimer’s Continues to Ris
7. Midlife Brain Activity a Predictor Of Alzheimer’s Diseas
8. New Drug Combination Found To Improve Memory in Alzheimer’s Patient
9. Blood Pressure An Early Warning Sign Of Alzheimer’s Disease
10. Delaying The Progression Of Alzheimer’s Disease
11. Hope For Patient With Alzheimer’s Diseas
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:10/13/2017)... , ... October 13, 2017 , ... “The Journey: From ... every danger possible to save lost souls in the Philippines. “The Journey: From the ... is a dedicated teacher of the Bible. She has taught all ages and currently ...
(Date:10/12/2017)... ... October 12, 2017 , ... Planet Fitness, one of the largest ... its plans to open a flagship location in Covington, LA at 401 N. U.S. ... Go store next to Office Depot in the Holiday Square shopping center. Its location ...
(Date:10/12/2017)... ... October 12, 2017 , ... Asante, a nationally ... care, have expanded their existing home health joint venture through an agreement, effective ... operating a joint venture home health company with Asante, delivering clinically integrated care, ...
(Date:10/12/2017)... ... October 12, 2017 , ... Leading pediatric oncology experts at Children’s National ... 49th Congress of the International Society of Paediatric Oncology (SIOP) Oct. 12-15. ... for Cancer and Blood Disorders at Children’s National, and Stephen P. Hunger, M.D., ...
(Date:10/12/2017)... ... October 12, 2017 , ... In the ... a year. In some states—like New York, New Jersey, Massachusetts, Texas, Virginia, Connecticut, ... retirement havens have extremely low property-tax rates, which contributes to the relatively lower ...
Breaking Medicine News(10 mins):
(Date:9/28/2017)... -- Hill-Rom Holdings, Inc. (NYSE: HRC), will host its ... on Friday, November 3, 2017, beginning at 7:00 a.m. ... 8:30 a.m. (CDT) / 9:30 a.m. (EDT). ... and guidance for 2018, Hill-Rom executives will also highlight ... and long-range financial outlook through 2020. ...
(Date:9/27/2017)... and NEW YORK , Sept. 27, 2017  DarioHealth ... and big data solutions, today announced that its MyDario product is expected ... local TV listings for when The Dr. Oz Show airs in your ... The nine-time Emmy ... ...
(Date:9/23/2017)... Sept. 22, 2017 Janssen Biotech, Inc. (Janssen) ... letter from the U.S. Food and Drug Administration (FDA) ... sirukumab for the treatment of moderately to severely active ... clinical data are needed to further evaluate the safety ... active RA. ...
Breaking Medicine Technology: